According to the new market research report "Vascular Closure Device Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) - Global Forecasts to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.
Don’t miss out on business opportunities in Vascular Closure Device Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=180101468
The report provides an overall understanding of the market. In this report, the market is segmented on the basis of type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Among these type segments, the passive approximators segment is expected to account for the largest share of the vascular closure devices market in 2017. The access segment includes femoral access and radial access. The procedure segment includes interventional cardiology and interventional radiology/vascular surgery. The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
All the possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
Browse and in-depth TOC on "Vascular Closure Device Market "
61 – Tables
30 - Figures
128 - Pages
Download an Illustrative overview of the report - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180101468
A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
Geographic analysis reveals that the North American segment is expected to account for the largest share of the market in 2017, owing to the increasing prevalence of cardiovascular diseases in the U.S., growing trend of one-day surgery for vascular procedures, and the increasing number of research and clinical trials for vascular closure devices.
Request for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=180101468
Vascular closure devices are relatively high-priced devices compared to manual compression devices. The average price of a vascular closure device is about USD 150–USD 250 while that of a manual compression device is about USD 15–USD 25. The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits.
Moreover, radial artery access makes it more convenient for doctors to achieve hemostasis using simple manual compression methods. Interventional procedures using radial artery access do not generally require vascular closure devices, which is another factor that leads to cost savings.
Key Players:
The major players in this market include Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), Cardiva Medical Inc. (U.S.), Morris Innovative, Inc. (U.S.), Medtronic plc (Ireland), Essential Medical, Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), TZ Medical, Inc. (U.S.), and Vasorum Ltd. (Ireland).
Vascular Closure Devices Market is expected to reach USD 984.6 Million by 2022
Vascular Closure Devices Market Analysis The vascular closure devices market is predicted to grow at a 6.8% CAGR over the forecast period (2018-2023), states the new Market Research Future (MRFR) report.
Besides, it also helps in reducing time to hospital discharge and time to ambulation.
Some of the drivers according to the Market Research Future (MRFR) the vascular closure device market report, include rising prevalence of various neurovascular and cardiovascular diseases, growing adoption of minimally invasive techniques, increasing investments by government organizations, and untapped market opportunities especially in emerging countries.
Based on access, the global vascular closure devices market is segmented into radial access and femoral access.
Based on end user, the vascular closure devices market is segmented into ambulatory surgery centers, specialty centers, hospitals and clinics, and others.
Vascular Closure Devices Market Regional Analysis Based on the region, the global vascular closure devices market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific, and the Middle East and Africa.
Vascular Closure Devices Market Research Report, by Product Type (Passive Vascular Closure Device, Active Vascular Closure Device, External Hemostatic Device), Access (Femoral, Radial), Procedures (Interventional Cardiology, Interventional Radiology), Application (Diagnostic, Therapeutic), End User (Hospitals & Clinics, ASCs) – Global Forecast Till 2023The report presents a detailed analysis of Vascular Closure Devices Market by providing readers with a comprehensive overview of the market’s historical trajectory.
The leading drivers and restraints affecting the global prostate cancer market are assessed in detail in the report.
The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period.Major Key PlayersTo gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch.Abbott Laboratories, Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Morris Innovative, Inc., Medtronic plc, Essential Medical, Inc., Merit Medical Systems, Inc., TZ Medical, Inc., Vasorum Ltd., Transluminal Technologies LLC, Vascular Closure Systems, Inc., Vivasure Medical Ltd., among others.Market Segment AnalysisPlug-Based DevicesSealant or Gel-Based DevicesCompression Assist DevicesActive Vascular Closure DevicesClip-Based DevicesSuture-Based DevicesGamma-Retroviral VectorsExternal Hemostatic DevicesGlobal Vascular Closure Devices Market, by AccessFemoral AccessRadial AccessGlobal Vascular Closure Devices Market, by ProceduresInterventional cardiologyInterventional radiology/vascular surgeryGlobal Vascular Closure Devices Market, by ApplicationDiagnostic InterventionTherapeutic InterventionVascular Closure Devices Market report offers insights into the leading market players and presents an assessment of their current market position.
Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M activities, and the latest R initiatives is also available in the reportRegional AnalysisGeographically, the global Vascular Closure Devices Market has been divided by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South AmericaBrowse Full Report Page Enabled with complete Table of Content at https://www.marketresearchfuture.com/reports/vascular-closure-devices-market-5704Chapters for This Vascular Closure Devices Market Study: -Chapter 1: to describe Global Vascular Closure Devices Market Introduction, product scope, market overview, market opportunities, market risk, market driving force;Chapter 2: to analyze the top manufacturers of Global Vascular Closure Devices Market, with sales, revenue, and price of Global Vascular Closure Devices Market.Chapter 3: to display the competitive situation among the top manufacturers, with sales, revenue and market share in Forecasted Time.Chapter 4: to show the Global Vascular Closure Devices Market by regions, with sales, revenue and market share of Global Vascular Closure Devices Market, for each region, during the forecast period.Chapter 5, 6, 7, 8 and 9: to analyze the key regions, with sales, revenue and market share by key countries in these regions;Chapter 10: to show the market by type and application, with sales market share and growth rate by type, application, Methodology, Analyst Introduction, Data Source By MRFRAbout Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:+1 646 845 9312 | Email: [email protected]
Upmarketresearch offers a latest published report on “global Vascular Closure Devices market analysis and forecast 2018-2023” delivering key insights and providing a competitive advantage to clients through a detailed report.
The report contains 108 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.Get exclusive free pdf sample copy of this report @https://www.upmarketresearch.com/home/requested_sample/6872Vascular Closure Devices industry research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.
Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
The numerical data is backed up by statistical tools such as swot analysis, bcg matrix, scot analysis, pestle analysis and so on.
The statistics are represented in graphical format for a clear understanding on facts and figures.The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
Secondary research techniques are implemented for better understanding and clarity for data analysis.The report for Vascular Closure Devices market analysis & forecast 2018-2023 is segmented into product segment, application segment & major players.Region-wise analysis global Vascular Closure Devices market covers: North america Europe China Japan India Southeast asia Other regions (central & south america, middle east & africa)The major players reported in the market include:Abbott LaboratoriesCardinal HealthSt.
Adroit Market Research launched a study titled, “Global Large Bore Vascular Closure Device Market Size 2017 By Product (Passive Closure Devices and Active Closure Devices), By Application (Femoral Arterial and Transradial Arterial), By Region and Forecast 2018 to 2025”.
The cost associated with the treatment and procedure is expected to reach approximately USD 900 billion by 2030.
With the increasing cardiovascular diseases in the US and spending by the public for treatment, there is tremendous opportunity for the companies who have their footprints in the vascular closure device market along with the new entrants who want to explore the market.Browse complete Global Large Bore Vascular Closure Device Market Report at: https://adroitmarketresearch.com/industry-reports/large-bore-vascular-closure-device-marketKey players within the global large bore vascular closure device industry include Abbott, Teleflex Incorporated, ESSENTIAL MEDICAL, INC, InSeal Medical, Terumo Medical Corporation, Transluminal Technologies, Vasorum Ltd., and Cardinal among others.
Market players are introducing and marketing new advanced and innovative vascular closure devices.
Launches such as these as well as increasing prevalence of CVDs are anticipated to augment the growth of the global large bore vascular closure devices over the next few years.Key segments of the global large bore vascular closure device marketProduct Overview, 2015-2025 (USD Million)Passive Closure DevicesActive Closure DevicesApplication Overview, 2015-2025 (USD Million)Femoral ArterialTransradial ArterialRegional Overview, 2015-2025 (USD Million)North AmericaS.CanadaEuropeUKGermanyFranceAsia-PacificJapanChinaIndiaCentral and South AmericaMiddle East and AfricaEnquire for buying Global Dietary Supplements Market Report at: https://adroitmarketresearch.com/contacts/enquiry-before-buying/810About Us:Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018.
Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry.
Market ScenarioGlobal Vascular Closure Devices Market was valued US$ 705 Mn in 2017 and is expected to reach US$ 1286.5 Mn by 2026, at a CAGR of 7.81 % during a forecast period.The vascular closure devices market is segmented into product, end user, access, hole size, and region.In terms of product, vascular closure devices market is segmented into passive approximators and active approximators.
Based on end user segment, vascular closure devices market is classified into interventional cardiology, interventional radiology & vascular surgery.
Based on regions, the global vascular closure devices market is divided into five main regions are North America, Europe, Asia-pacific, Latin America and Middle East & Africa.For more info, Get PDF at: https://www.trendsmarketresearch.com/report/sample/11285Global Vascular Closure Devices MarketVascular closure devices are used to achieve hemostasis after a cardiovascular procedure.
In terms of product, Active approximators dominated the VCD industry owing to high-efficiency rate and presence of broad product portfolio in this segment.
Passive approximators are the fastest growing segment as they provide reliable and quick hemostasis of vascular access site.On the basis of the end user, the interventional cardiology segment is expected to dominate the market due to the high prevalence of cardiovascular diseases and the rapidly increasing heavy population.Based on access, the femoral access segment is estimated to account for the largest share of the market owing to an increasing number of cardiologists and physicians opting for femoral access in interventional procedures, the market is expected to witness significant growth during the forecast period.High prevalence of cardiovascular diseases, high incidence of obesity and a rising need for minimally invasive procedures are boosting the global vascular closure devices market growth.
Additionally, increasing healthcare expenditure and demand for new treatment options along with the rise in government support are expected to drive the growth of the market.The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the market.You can Buy This Report from Here @ https://www.trendsmarketresearch.com/checkout/11285/SingleNeed for highly skilled professionals is the major challenge for the global vascular closure devices market.
Central venous/vascular access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream.
Venous access devices that can be implanted under the skin were introduced in 1982.
They allow medications to be delivered directly into larger veins, are less likely to clot, and can be left in for long periods.
The CVAD may contain one or two tubes.
When a CVAD contains two tubes, it is called a double or dual lumen catheter and may also be used for injecting contrast for CT or MRI scans (depending on type of CVAD).In terms of percentage share contribution by product, the peripheral catheters segment is expected to account for 48.24% by 2025, emerging as the leading segment by value.The central vascular access devices market is largely consolidated, with the top five players accounting for a share of over 69% in 2017.
Bard, Teleflex, Inc., Terumo Corporation, Smiths Medical, Inc and Edwards Lifesciences Corporation are leading the market, other prominent players include Becton Dickinson, B.Braun, Vygon Ltd, AngioDynamics.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-central-vascular-access-device-2019-2024-767According to this study, over the next five years the Central Vascular Access Device market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 2410 million by 2024, from US$ 1850 million in 2019.
11 February 2020 - The global Peripheral Vascular Device Market size was estimated at USD 5,888.5 million in 2014 and is expected to grow at a CAGR of 7.2% over the forecast period.
According to an estimate of Central Disease for Control and Prevention, about 8.5 million people in the U.S have peripheral artery disease including 12-20% of individuals ageing 60 years and above.
Rising chronic conditions including diabetes, obesity and end-stage renal disease is one of the crucial factors anticipated to boost demand for these devices.
However, the market growth is expected to negatively impact the market owing to factors such as reimbursement issues in developing countries, stringent regulatory policies, and presence of highly fragmented market.
Product Insights Based on the products, the market is segmented as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters.
Peripheral angioplasty balloon catheters held significant market share owing to introduction of technological advance products like drug coated balloons and favorable reimbursement policies in developed countries like Germany and the U.S.
Left Atrial Appendage Closure Device Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Left Atrial Appendage Closure Device Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/left-atrial-appendage-closure-device-market/download-sampleMarket DynamicsStroke is a serious risk for patients with atrial fibrillation.
Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world.
Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market.
Vascular Closure Devices Market Analysis The vascular closure devices market is predicted to grow at a 6.8% CAGR over the forecast period (2018-2023), states the new Market Research Future (MRFR) report.
Besides, it also helps in reducing time to hospital discharge and time to ambulation.
Some of the drivers according to the Market Research Future (MRFR) the vascular closure device market report, include rising prevalence of various neurovascular and cardiovascular diseases, growing adoption of minimally invasive techniques, increasing investments by government organizations, and untapped market opportunities especially in emerging countries.
Based on access, the global vascular closure devices market is segmented into radial access and femoral access.
Based on end user, the vascular closure devices market is segmented into ambulatory surgery centers, specialty centers, hospitals and clinics, and others.
Vascular Closure Devices Market Regional Analysis Based on the region, the global vascular closure devices market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific, and the Middle East and Africa.
Vascular Closure Devices Market Research Report, by Product Type (Passive Vascular Closure Device, Active Vascular Closure Device, External Hemostatic Device), Access (Femoral, Radial), Procedures (Interventional Cardiology, Interventional Radiology), Application (Diagnostic, Therapeutic), End User (Hospitals & Clinics, ASCs) – Global Forecast Till 2023The report presents a detailed analysis of Vascular Closure Devices Market by providing readers with a comprehensive overview of the market’s historical trajectory.
The leading drivers and restraints affecting the global prostate cancer market are assessed in detail in the report.
The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period.Major Key PlayersTo gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch.Abbott Laboratories, Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Morris Innovative, Inc., Medtronic plc, Essential Medical, Inc., Merit Medical Systems, Inc., TZ Medical, Inc., Vasorum Ltd., Transluminal Technologies LLC, Vascular Closure Systems, Inc., Vivasure Medical Ltd., among others.Market Segment AnalysisPlug-Based DevicesSealant or Gel-Based DevicesCompression Assist DevicesActive Vascular Closure DevicesClip-Based DevicesSuture-Based DevicesGamma-Retroviral VectorsExternal Hemostatic DevicesGlobal Vascular Closure Devices Market, by AccessFemoral AccessRadial AccessGlobal Vascular Closure Devices Market, by ProceduresInterventional cardiologyInterventional radiology/vascular surgeryGlobal Vascular Closure Devices Market, by ApplicationDiagnostic InterventionTherapeutic InterventionVascular Closure Devices Market report offers insights into the leading market players and presents an assessment of their current market position.
Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M activities, and the latest R initiatives is also available in the reportRegional AnalysisGeographically, the global Vascular Closure Devices Market has been divided by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South AmericaBrowse Full Report Page Enabled with complete Table of Content at https://www.marketresearchfuture.com/reports/vascular-closure-devices-market-5704Chapters for This Vascular Closure Devices Market Study: -Chapter 1: to describe Global Vascular Closure Devices Market Introduction, product scope, market overview, market opportunities, market risk, market driving force;Chapter 2: to analyze the top manufacturers of Global Vascular Closure Devices Market, with sales, revenue, and price of Global Vascular Closure Devices Market.Chapter 3: to display the competitive situation among the top manufacturers, with sales, revenue and market share in Forecasted Time.Chapter 4: to show the Global Vascular Closure Devices Market by regions, with sales, revenue and market share of Global Vascular Closure Devices Market, for each region, during the forecast period.Chapter 5, 6, 7, 8 and 9: to analyze the key regions, with sales, revenue and market share by key countries in these regions;Chapter 10: to show the market by type and application, with sales market share and growth rate by type, application, Methodology, Analyst Introduction, Data Source By MRFRAbout Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:+1 646 845 9312 | Email: [email protected]
Upmarketresearch offers a latest published report on “global Vascular Closure Devices market analysis and forecast 2018-2023” delivering key insights and providing a competitive advantage to clients through a detailed report.
The report contains 108 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.Get exclusive free pdf sample copy of this report @https://www.upmarketresearch.com/home/requested_sample/6872Vascular Closure Devices industry research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.
Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
The numerical data is backed up by statistical tools such as swot analysis, bcg matrix, scot analysis, pestle analysis and so on.
The statistics are represented in graphical format for a clear understanding on facts and figures.The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
Secondary research techniques are implemented for better understanding and clarity for data analysis.The report for Vascular Closure Devices market analysis & forecast 2018-2023 is segmented into product segment, application segment & major players.Region-wise analysis global Vascular Closure Devices market covers: North america Europe China Japan India Southeast asia Other regions (central & south america, middle east & africa)The major players reported in the market include:Abbott LaboratoriesCardinal HealthSt.
Left Atrial Appendage Closure Device Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Left Atrial Appendage Closure Device Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/left-atrial-appendage-closure-device-market/download-sampleMarket DynamicsStroke is a serious risk for patients with atrial fibrillation.
Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world.
Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market.
Adroit Market Research launched a study titled, “Global Large Bore Vascular Closure Device Market Size 2017 By Product (Passive Closure Devices and Active Closure Devices), By Application (Femoral Arterial and Transradial Arterial), By Region and Forecast 2018 to 2025”.
The cost associated with the treatment and procedure is expected to reach approximately USD 900 billion by 2030.
With the increasing cardiovascular diseases in the US and spending by the public for treatment, there is tremendous opportunity for the companies who have their footprints in the vascular closure device market along with the new entrants who want to explore the market.Browse complete Global Large Bore Vascular Closure Device Market Report at: https://adroitmarketresearch.com/industry-reports/large-bore-vascular-closure-device-marketKey players within the global large bore vascular closure device industry include Abbott, Teleflex Incorporated, ESSENTIAL MEDICAL, INC, InSeal Medical, Terumo Medical Corporation, Transluminal Technologies, Vasorum Ltd., and Cardinal among others.
Market players are introducing and marketing new advanced and innovative vascular closure devices.
Launches such as these as well as increasing prevalence of CVDs are anticipated to augment the growth of the global large bore vascular closure devices over the next few years.Key segments of the global large bore vascular closure device marketProduct Overview, 2015-2025 (USD Million)Passive Closure DevicesActive Closure DevicesApplication Overview, 2015-2025 (USD Million)Femoral ArterialTransradial ArterialRegional Overview, 2015-2025 (USD Million)North AmericaS.CanadaEuropeUKGermanyFranceAsia-PacificJapanChinaIndiaCentral and South AmericaMiddle East and AfricaEnquire for buying Global Dietary Supplements Market Report at: https://adroitmarketresearch.com/contacts/enquiry-before-buying/810About Us:Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018.
Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry.
Market ScenarioGlobal Vascular Closure Devices Market was valued US$ 705 Mn in 2017 and is expected to reach US$ 1286.5 Mn by 2026, at a CAGR of 7.81 % during a forecast period.The vascular closure devices market is segmented into product, end user, access, hole size, and region.In terms of product, vascular closure devices market is segmented into passive approximators and active approximators.
Based on end user segment, vascular closure devices market is classified into interventional cardiology, interventional radiology & vascular surgery.
Based on regions, the global vascular closure devices market is divided into five main regions are North America, Europe, Asia-pacific, Latin America and Middle East & Africa.For more info, Get PDF at: https://www.trendsmarketresearch.com/report/sample/11285Global Vascular Closure Devices MarketVascular closure devices are used to achieve hemostasis after a cardiovascular procedure.
In terms of product, Active approximators dominated the VCD industry owing to high-efficiency rate and presence of broad product portfolio in this segment.
Passive approximators are the fastest growing segment as they provide reliable and quick hemostasis of vascular access site.On the basis of the end user, the interventional cardiology segment is expected to dominate the market due to the high prevalence of cardiovascular diseases and the rapidly increasing heavy population.Based on access, the femoral access segment is estimated to account for the largest share of the market owing to an increasing number of cardiologists and physicians opting for femoral access in interventional procedures, the market is expected to witness significant growth during the forecast period.High prevalence of cardiovascular diseases, high incidence of obesity and a rising need for minimally invasive procedures are boosting the global vascular closure devices market growth.
Additionally, increasing healthcare expenditure and demand for new treatment options along with the rise in government support are expected to drive the growth of the market.The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the market.You can Buy This Report from Here @ https://www.trendsmarketresearch.com/checkout/11285/SingleNeed for highly skilled professionals is the major challenge for the global vascular closure devices market.
Central venous/vascular access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream.
Venous access devices that can be implanted under the skin were introduced in 1982.
They allow medications to be delivered directly into larger veins, are less likely to clot, and can be left in for long periods.
The CVAD may contain one or two tubes.
When a CVAD contains two tubes, it is called a double or dual lumen catheter and may also be used for injecting contrast for CT or MRI scans (depending on type of CVAD).In terms of percentage share contribution by product, the peripheral catheters segment is expected to account for 48.24% by 2025, emerging as the leading segment by value.The central vascular access devices market is largely consolidated, with the top five players accounting for a share of over 69% in 2017.
Bard, Teleflex, Inc., Terumo Corporation, Smiths Medical, Inc and Edwards Lifesciences Corporation are leading the market, other prominent players include Becton Dickinson, B.Braun, Vygon Ltd, AngioDynamics.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-central-vascular-access-device-2019-2024-767According to this study, over the next five years the Central Vascular Access Device market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 2410 million by 2024, from US$ 1850 million in 2019.
11 February 2020 - The global Peripheral Vascular Device Market size was estimated at USD 5,888.5 million in 2014 and is expected to grow at a CAGR of 7.2% over the forecast period.
According to an estimate of Central Disease for Control and Prevention, about 8.5 million people in the U.S have peripheral artery disease including 12-20% of individuals ageing 60 years and above.
Rising chronic conditions including diabetes, obesity and end-stage renal disease is one of the crucial factors anticipated to boost demand for these devices.
However, the market growth is expected to negatively impact the market owing to factors such as reimbursement issues in developing countries, stringent regulatory policies, and presence of highly fragmented market.
Product Insights Based on the products, the market is segmented as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters.
Peripheral angioplasty balloon catheters held significant market share owing to introduction of technological advance products like drug coated balloons and favorable reimbursement policies in developed countries like Germany and the U.S.